Metrics Inc. is a full-service CDMO serving clients worldwide. The company’s areas of expertise in solid dose development include pharmaceutical formulation development; first-time-in-man (FTIM) formulations; clinical material manufacturing (CTM) for Phases I, II and III; and analytical method development and validation services leading to commercial scale manufacturing. Metrics’ technical capabilities include expertise in highly potent, cytotoxic, insoluble, and unstable compounds and Schedule II-V controlled substances.
E-mail: marketing@MetricsInc.com